Galecto, Inc.
SEC Filing List
GLTO CIK: 0001800315
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 3 | Initial statement of beneficial ownershi... | Cheng Andrew | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/13/2026 | |
| 4 | Statement of changes in beneficial owner... | Cheng Andrew | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/13/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 08/12/2026 | ||
| S-8 POS | Post-effective amendment to an S-8 regis... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| 8-A12B/A | Amendment to Form for the registration /... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/10/2026 | |
| No record found. | |||||
| Load More | |||||
